Lsv Asset Management Gilead Sciences, Inc. Transaction History

Lsv Asset Management

$46.7 Billion
Q3 2024

A detailed history of Lsv Asset Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lsv Asset Management holds 5,287,868 shares of GILD stock, worth $483 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

5,287,868

Previous 5,509,889 4.03%

Holding current value

$483 Million

Previous $378 Million 17.27%

% of portfolio

0.95%

Previous 0.83%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $14.8 Million - $18.6 Million	-222,021 Reduced 4.03%	5,287,868 $443 Million
Q2 2024 Aug 06, 2024	SELL	$63.15 - $72.88 $10.5 Million - $12.2 Million	-166,860 Reduced 2.94%	5,509,889 $378 Million
Q1 2024 May 06, 2024	SELL	$71.58 - $87.29 $18 Million - $21.9 Million	-251,250 Reduced 4.24%	5,676,749 $416 Million
Q4 2023 Feb 06, 2024	SELL	$73.27 - $83.09 $15.4 Million - $17.5 Million	-210,210 Reduced 3.42%	5,927,999 $480 Million
Q3 2023 Nov 03, 2023	SELL	$73.94 - $80.67 $11.4 Million - $12.4 Million	-154,260 Reduced 2.45%	6,138,209 $460 Million
Q2 2023 Aug 02, 2023	SELL	$76.01 - $86.7 $14.6 Million - $16.7 Million	-192,260 Reduced 2.96%	6,292,469 $485 Million
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $6.26 Million - $7.13 Million	-80,949 Reduced 1.23%	6,484,729 $538 Million
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $7.28 Million - $10.5 Million	-116,851 Reduced 1.75%	6,565,678 $564 Million
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $8.09 Million - $9.24 Million	135,802 Added 2.07%	6,682,529 $412 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $57.6 Million - $64.9 Million	998,538 Added 18.0%	6,546,727 $405 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $25.8 Million - $32.3 Million	445,089 Added 8.72%	5,548,189 $330 Million
Q4 2021 Jan 28, 2022	BUY	$64.88 - $73.64 $49.9 Million - $56.7 Million	769,409 Added 17.75%	5,103,100 $371 Million
Q3 2021 Nov 04, 2021	BUY	$67.69 - $73.03 $11.6 Million - $12.5 Million	170,913 Added 4.11%	4,333,691 $303 Million
Q2 2021 Aug 04, 2021	SELL	$63.47 - $69.35 $1.63 Million - $1.78 Million	-25,672 Reduced 0.61%	4,162,778 $287 Million
Q1 2021 Apr 30, 2021	SELL	$60.0 - $68.46 $12 Million - $13.7 Million	-200,200 Reduced 4.56%	4,188,450 $271 Million
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $11 Million - $12.5 Million	-193,500 Reduced 4.22%	4,388,650 $256 Million
Q3 2020 Oct 23, 2020	BUY	$62.1 - $78.08 $4.35 Million - $5.46 Million	69,982 Added 1.55%	4,582,150 $290 Million
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $1.23 Million - $1.42 Million	16,944 Added 0.38%	4,512,168 $347 Million
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $5.79 Million - $7.42 Million	-92,467 Reduced 2.02%	4,495,224 $336 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $3.37 Million - $3.71 Million	54,747 Added 1.21%	4,587,691 $298 Million
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $7.69 Million - $8.49 Million	-123,000 Reduced 2.64%	4,532,944 $287 Million
Q2 2019 Aug 08, 2019	SELL	$61.87 - $69.38 $1.89 Million - $2.12 Million	-30,557 Reduced 0.65%	4,655,944 $315 Million
Q1 2019 May 07, 2019	BUY	$62.53 - $70.05 $2.34 Million - $2.62 Million	37,464 Added 0.81%	4,686,501 $305 Million
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $3.99 Million - $5.2 Million	-65,866 Reduced 1.4%	4,649,037 $291 Million
Q3 2018 Nov 06, 2018	BUY	$71.28 - $78.92 $313,560 - $347,169	4,399 Added 0.09%	4,714,903 $364 Million
Q2 2018 Aug 08, 2018	BUY	$64.88 - $75.68 $2.88 Million - $3.36 Million	44,427 Added 0.95%	4,710,504 $334 Million
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $7.75 Million - $9.45 Million	106,380 Added 2.33%	4,666,077 $352 Million
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $64.5 Million - $75.7 Million	906,959 Added 24.83%	4,559,697 $0
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $263 Million - $312 Million	3,652,738	3,652,738 $296 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management Gilead Sciences, Inc. Transaction History